Studying Patterns in Patient Engagement Among Tardive Dyskinesia Patients

Status Not yet recruiting

Clinical Trial Summary

The statistical analysis of the collected data aims to reveal the many factors that influence patient involvement in clinical trials. Findings will be disseminated through conferences and scholarly papers to benefit all parties participating in clinical trials. These findings will help to shape the design of future clinical trials for people with tardive dyskinesia, as well as enhance recruiting techniques and retention rates.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06218719
Study type	Observational
Source	Power Life Sciences Inc.
Contact	Michael B Gill
Phone	4159004227
Email	bask@withpower.com
Status	Not yet recruiting
Phase
Start date	February 2025
Completion date	February 2027

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02840760` - Repetitive Transcranial Magnetic Stimulation for the Treatment of the Tardive Dyskinesia.	N/A
Completed	`NCT01688037` - NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)	Phase 2
Completed	`NCT01391390` - Melatonin Treatment for Tardive Dyskinesia in Schizophrenia	N/A
Withdrawn	`NCT03254186` - Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia	Phase 2/Phase 3
Completed	`NCT02291861` - Addressing Involuntary Movements in Tardive Dyskinesia	Phase 3
Completed	`NCT02274558` - A Phase 3 Study of NBI-98854 for the Treatment of Tardive Dyskinesia	Phase 3
Completed	`NCT02198794` - Reducing Involuntary Movements in Participants With Tardive Dyskinesia	Phase 3
Completed	`NCT01467089` - The Assessment of Movement Disorders Utilizing Live Two-Way Video	N/A
Completed	`NCT04794413` - Pimavanserin Treatment in TS	Early Phase 1
Recruiting	`NCT06011408` - Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes	N/A
Recruiting	`NCT05859698` - Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia	Phase 4
Active, not recruiting	`NCT02252380` - ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders	N/A
Terminated	`NCT00917293` - Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia	Phase 2
Completed	`NCT01543321` - Xenazine in Late Dyskinetic Syndrome With Neuroleptics	Phase 3
Not yet recruiting	`NCT06107829` - Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities	Phase 4
Completed	`NCT02405091` - Safety and Tolerability Study of NBI-98854 for the Treatment of Tardive Dyskinesia	Phase 3
Completed	`NCT03176771` - Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia	Phase 2/Phase 3
Terminated	`NCT02524886` - Deep Brain Stimulation for Patients With Tardive Dyskinesia and or Dystonia	N/A
Completed	`NCT02195700` - Aim to Reduce Movements in Tardive Dyskinesia	Phase 2/Phase 3
Completed	`NCT02736955` - Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia	Phase 3